Estimaciones de analistas de Wall Street para Armata Pharmaceuticals, Inc. (ARMP): precio objetivo de consenso, recomendaciones de compra/mantener/venta y previsiones de ingresos, BPA y EBITDA para los próximos ejercicios.
Sorpresas de Resultados Recientes
| Fecha | BPA Real | BPA Estimado | vs Est. |
|---|---|---|---|
| 2026-11-11 | $-0.57 | ||
| 2026-08-12 | $-0.27 | $-0.45 | +39.3% |
| 2026-05-13 | $-3.16 | $-0.38 | -731.6% |
| 2026-03-25 | $-3.42 | $-0.19 | -1700.0% |
| 2025-11-12 | $-0.74 | $-0.42 | -76.2% |
| 2025-08-12 | $-0.45 | $-0.39 | -15.4% |
| 2025-05-14 | $-0.20 | $-0.38 | +47.4% |
| 2025-03-20 | $-0.23 | $-0.35 | +34.3% |
Ratios de valoración
| Precio / Valor contable | -0.60 |
| EV / EBITDA | -2.89 |
| Rentabilidad por dividendo | 0.00% |
Cuenta de Resultados (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Ingresos | $260000 | $115000 | 0 | 0 | $823000 | $4.5M | $5.5M | $4.5M | $5.2M | $4.9M |
| Coste de Ventas | $369000 | $374000 | $1.4M | $1.4M | $14.4M | $20.0M | $35.0M | $972000 | $34.4M | $1.5M |
| Beneficio Bruto | -$109000 | -$259000 | -$1.4M | -$1.4M | -$13.6M | -$15.5M | -$29.5M | $3.6M | -$29.3M | $3.4M |
| I+D | $5.7M | $2.9M | $4.9M | $9.8M | $14.4M | $20.0M | $35.0M | $33.8M | $34.4M | $23.7M |
| Generales y Administrativos | $8.4M | $7.6M | $5.7M | $7.9M | $8.0M | $8.3M | $7.4M | $10.7M | $13.2M | $12.4M |
| Gastos Operativos | $23.6M | $16.3M | $9.5M | $17.7M | $8.0M | $8.3M | $7.4M | $44.4M | $13.2M | $34.6M |
| Beneficio Operativo | -$23.4M | -$16.2M | -$12.5M | -$19.1M | -$21.6M | -$23.8M | -$36.9M | -$40.9M | -$42.4M | -$31.2M |
| EBITDA | -$13.5M | -$10.0M | -$9.5M | -$17.2M | -$20.4M | -$21.9M | -$36.0M | -$65.4M | -$6.8M | -$155.7M |
| Gastos por Intereses | 0 | 0 | 0 | $931000 | $628000 | $64000 | $29000 | $2.6M | $10.7M | $16.6M |
| Beneficio Antes de Impuestos | -$19.4M | -$14.1M | -$16.7M | -$19.5M | -$22.2M | -$23.2M | -$36.9M | -$69.0M | -$18.9M | -$173.8M |
| Impuestos | -$556000 | -$1.3M | -$328000 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Beneficio Neto | -$18.8M | -$12.8M | -$12.1M | -$19.5M | -$22.2M | -$23.2M | -$36.9M | -$69.0M | -$18.9M | -$173.8M |
| BPA | $-345.80 | $-28.14 | $-8.90 | $-2.43 | $-1.35 | $-0.96 | $-1.08 | $-1.91 | $-0.52 | $-4.80 |
| BPA Diluido | $-345.80 | $-27.34 | $-8.90 | $-2.43 | $-1.35 | $-0.96 | $-1.08 | $-1.91 | $-0.52 | $-4.80 |
| Acciones en Circulación (Diluidas) | $7027 | $456244 | $332341 | $7.8M | $16.4M | $24.1M | $34.3M | $36.1M | $36.2M | $36.2M |
Precio
| Precio | $4.07 |
| Capitalización | $149M |
| Bolsa | AMEX |
| País | US |
Empresas relacionadas: CCCC · CDXS · GNFT · IMDX · IPHA · NTHI · NVCT
Explorar sector: Healthcare · Biotechnology
Más secciones de ARMP: Resumen · Financieros · Valoración · Estadísticas · Técnico · Propiedad · Noticias · Eventos
Descubre más: Radar — señales de acciones infravaloradas · Academia de Inversión — aprende a analizar acciones